Interferon and biologic signatures in dermatomyositis skin: Specificity and heterogeneity across diseases

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Wong, David ^a   Kea, Bory ^a   Pesich, Rob ^a   Higgs, Brandon W ^b   Zhu, Wei ^b   Brown, Patrick ^a   Yao, Yihong ^b   Fiorentino, David ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MEDIMMUNE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; COMPLEMENT; GAMMA INTERFERON; INTERFERON; INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 6; KAPPA INTERFERON; MESSENGER RNA; OMEGA INTERFERON; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; TRANSCRIPTOME;

ACNE VULGARIS; ADULT; ARTICLE; ATOPIC DERMATITIS; CELL ACTIVATION; CELL DIFFERENTIATION; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; CONTACT DERMATITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DERMATOMYOSITIS; EPIDERMIS CELL; GENE; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC HETEROGENEITY; GENETIC TRANSCRIPTION; HERPES SIMPLEX; HUMAN; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INTERFERON INDUCIBLE GENE; LUPUS VULGARIS; MORPHEA; PSORIASIS; QUANTITATIVE ANALYSIS; SCLERODERMA; SKIN INFLAMMATION; SYSTEMIC SCLEROSIS; UPREGULATION; CASE CONTROL STUDY; DNA MICROARRAY; GENETIC MARKER; GENETICS; MIDDLE AGED; PATHOLOGY;

HERPES;

ADULT; CASE-CONTROL STUDIES; DERMATOMYOSITIS; GENETIC MARKERS; HUMANS; INTERFERONS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSCRIPTOME;

EID: 84855326096     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029161     Document Type: Article

References (36)

1. Mammen AL, (2010) Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis. Ann N Y Acad Sci 1184: 134-153.
2. O'Hanlon TP, Miller FW, (2009) Genetic risk and protective factors for the idiopathic inflammatory myopathies. Curr Rheumatol Rep 11: 287-294.
3. Greenberg SA, Amato AA, (2004) Uncertainties in the pathogenesis of adult dermatomyositis. Curr Opin Neurol 17: 359-364.
4. Arahata K, Engel AG, (1984) Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells. Ann Neurol 16: 193-208.
5. Page G, Chevrel G, Miossec P, (2004) Anatomic localization of immature and mature dendritic cell subsets in dermatomyositis and polymyositis: Interaction with chemokines and Th1 cytokine-producing cells. Arthritis Rheum 50: 199-208.
6. De Paepe B, Creus KK, De Bleecker JL, (2009) Role of cytokines and chemokines in idiopathic inflammatory myopathies. Curr Opin Rheumatol 21: 610-616.
7. Greenberg SA, (2010) Dermatomyositis and type 1 interferons. Curr Rheumatol Rep 12: 198-203.
8. Niewold TB, Kariuki SN, Morgan GA, Shrestha S, Pachman LM, (2009) Elevated serum interferon-alpha activity in juvenile dermatomyositis: associations with disease activity at diagnosis and after thirty-six months of therapy. Arthritis Rheum 60: 1815-1824.
9. Baechler EC, Bauer JW, Slattery CA, Ortmann WA, Espe KJ, et al. (2007) An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity. Mol Med 13: 59-68.
10. Walsh RJ, Kong SW, Yao Y, Jallal B, Kiener PA, et al. (2007) Type I interferon-inducible gene expression in blood is present and reflects disease activity in dermatomyositis and polymyositis. Arthritis Rheum 56: 3784-3792.
11. Krathen MS, Fiorentino D, Werth VP, (2008) Dermatomyositis. Curr Dir Autoimmun 10: 313-332.
12. Crowson AN, Magro CM, (1996) The role of microvascular injury in the pathogenesis of cutaneous lesions of dermatomyositis. Hum Pathol 27: 15-19.
13. Mascaro JM Jr, Hausmann G, Herrero C, Grau JM, Cid MC, et al. (1995) Membrane attack complex deposits in cutaneous lesions of dermatomyositis. Arch Dermatol 131: 1386-1392.
14. Magro CM, Crowson AN, (1997) The immunofluorescent profile of dermatomyositis: a comparative study with lupus erythematosus. J Cutan Pathol 24: 543-552.
15. Wenzel J, Scheler M, Bieber T, Tuting T, (2005) Evidence for a role of type I interferons in the pathogenesis of dermatomyositis. Br J Dermatol 153: 462-463; author reply 463-464.
16. Wenzel J, Schmidt R, Proelss J, Zahn S, Bieber T, et al. (2006) Type I interferon-associated skin recruitment of CXCR3+ lymphocytes in dermatomyositis. Clin Exp Dermatol 31: 576-582.
17. Shrestha S, Wershil B, Sarwark JF, Niewold TB, Philipp T, et al. (2010) Lesional and nonlesional skin from patients with untreated juvenile dermatomyositis displays increased numbers of mast cells and mature plasmacytoid dendritic cells. Arthritis Rheum 62: 2813-2822.
18. McNiff JM, Kaplan DH, (2008) Plasmacytoid dendritic cells are present in cutaneous dermatomyositis lesions in a pattern distinct from lupus erythematosus. J Cutan Pathol 35: 452-456.
19. Greenberg SA, Fiorentino D, (2009) Similar topology of injury to keratinocytes and myofibres in dermatomyositis skin and muscle. Br J Dermatol 160: 464-465.
20. Callen JP, Wortmann RL, (2006) Dermatomyositis. Clin Dermatol 24: 363-373.
21. Caproni M, Torchia D, Cardinali C, Volpi W, Del Bianco E, et al. (2004) Infiltrating cells, related cytokines and chemokine receptors in lesional skin of patients with dermatomyositis. Br J Dermatol 151: 784-791.
22. Saaf AM, Tengvall-Linder M, Chang HY, Adler AS, Wahlgren CF, et al. (2008) Global expression profiling in atopic eczema reveals reciprocal expression of inflammatory and lipid genes. PLoS One 3: e4017.
23. Gudjonsson JE, Ding J, Johnston A, Tejasvi T, Guzman AM, et al. (2010) Assessment of the psoriatic transcriptome in a large sample: additional regulated genes and comparisons with in vitro models. J Invest Dermatol 130: 1829-1840.
24. Der SD, Zhou A, Williams BR, Silverman RH, (1998) Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays. Proc Natl Acad Sci U S A 95: 15623-15628.
25. Sanda C, Weitzel P, Tsukahara T, Schaley J, Edenberg HJ, et al. (2006) Differential gene induction by type I and type II interferons and their combination. J Interferon Cytokine Res 26: 462-472.
26. Indraccolo S, Pfeffer U, Minuzzo S, Esposito G, Roni V, et al. (2007) Identification of genes selectively regulated by IFNs in endothelial cells. J Immunol 178: 1122-1135.
27. Gudjonsson JE, Ding J, Li X, Nair RP, Tejasvi T, et al. (2009) Global gene expression analysis reveals evidence for decreased lipid biosynthesis and increased innate immunity in uninvolved psoriatic skin. J Invest Dermatol 129: 2795-2804.
28. Yao Y, Richman L, Higgs BW, Morehouse CA, de los Reyes M, et al. (2009) Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus. Arthritis Rheum 60: 1785-1796.
29. Plager DA, Leontovich AA, Henke SA, Davis MD, McEvoy MT, et al. (2007) Early cutaneous gene transcription changes in adult atopic dermatitis and potential clinical implications. Exp Dermatol 16: 28-36.
30. Greenberg SA, Pinkus JL, Pinkus GS, Burleson T, Sanoudou D, et al. (2005) Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol 57: 664-678.
31. Tezak Z, Hoffman EP, Lutz JL, Fedczyna TO, Stephan D, et al. (2002) Gene expression profiling in DQA1*0501+ children with untreated dermatomyositis: a novel model of pathogenesis. J Immunol 168: 4154-4163.
32. Yao Y, Richman L, Morehouse C, de los Reyes M, Higgs BW, et al. (2008) Type I interferon: potential therapeutic target for psoriasis? PLoS One 3: e2737.
33. Wenzel J, Tuting T, (2008) An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in "interface dermatitis". J Invest Dermatol 128: 2392-2402.
34. Ghoreishi M, Martinka M, Dutz JP, (2010) Type 1 interferon signature in the scalp lesions of alopecia areata. Br J Dermatol 163: 57-62.
35. Sontheimer RD, (2002) Dermatomyositis: an overview of recent progress with emphasis on dermatologic aspects. Dermatol Clin 20: 387-408.
36. Milano A, Pendergrass SA, Sargent JL, George LK, McCalmont TH, et al. (2008) Molecular subsets in the gene expression signatures of scleroderma skin. PLoS One 3: e2696.